212 related articles for article (PubMed ID: 29741512)
1. Advances in CAR T-cell therapy for chronic lymphocytic leukemia.
Porter DL
Clin Adv Hematol Oncol; 2018 Feb; 16(2):118-120. PubMed ID: 29741512
[No Abstract] [Full Text] [Related]
2. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
Singh N; Frey NV; Grupp SA; Maude SL
Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
[TBL] [Abstract][Full Text] [Related]
3. CARs in chronic lymphocytic leukemia -- ready to drive.
Hosing C; Kebriaei P; Wierda W; Jena B; Cooper LJN; Shpall E
Curr Hematol Malig Rep; 2013 Mar; 8(1):60-70. PubMed ID: 23225251
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?
Rhodes JM; Schuster SJ
Cancer J; 2019; 25(6):436-441. PubMed ID: 31764125
[TBL] [Abstract][Full Text] [Related]
5. CARs in the Lead Against Multiple Myeloma.
Ormhøj M; Bedoya F; Frigault MJ; Maus MV
Curr Hematol Malig Rep; 2017 Apr; 12(2):119-125. PubMed ID: 28233151
[TBL] [Abstract][Full Text] [Related]
6. Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.
Fraietta JA; Schwab RD; Maus MV
Semin Oncol; 2016 Apr; 43(2):291-9. PubMed ID: 27040708
[TBL] [Abstract][Full Text] [Related]
7. Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
Shah N; Rezvani K; Hosing C; Kebriaei P; Wierda W; Cooper L; Shpall E
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl(Suppl):S18-22. PubMed ID: 25486950
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor T cell therapy: 25years in the making.
Gill S; Maus MV; Porter DL
Blood Rev; 2016 May; 30(3):157-67. PubMed ID: 26574053
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review.
Mato AR; Thompson MC; Nabhan C; Svoboda J; Schuster SJ
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):852-856. PubMed ID: 28826693
[TBL] [Abstract][Full Text] [Related]
10. Are chimeric antigen receptor T cells ready for prime time?
Brentjens RJ
Clin Adv Hematol Oncol; 2016 Jan; 14(1):17-9. PubMed ID: 27057662
[No Abstract] [Full Text] [Related]
11. T-Cell Therapy Has Lasting Effects.
Cancer Discov; 2016 Feb; 6(2):113. PubMed ID: 26719386
[TBL] [Abstract][Full Text] [Related]
12. From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer.
Dummy
EBioMedicine; 2016 Dec; 14():1-2. PubMed ID: 27986279
[No Abstract] [Full Text] [Related]
13. CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target.
Holzinger A; Abken H
Cancer Immunol Immunother; 2017 Nov; 66(11):1505-1507. PubMed ID: 28755091
[No Abstract] [Full Text] [Related]
14. Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.
Srivastava S; Riddell SR
J Immunol; 2018 Jan; 200(2):459-468. PubMed ID: 29311388
[TBL] [Abstract][Full Text] [Related]
15. CAR T-cell therapy: Full speed ahead.
Sermer D; Brentjens R
Hematol Oncol; 2019 Jun; 37 Suppl 1():95-100. PubMed ID: 31187533
[TBL] [Abstract][Full Text] [Related]
16. Advances in off-the-shelf CAR T-cell therapy.
Benjamin R
Clin Adv Hematol Oncol; 2019 Mar; 17(3):155-157. PubMed ID: 30969953
[No Abstract] [Full Text] [Related]
17. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
Peinert S; Kershaw MH; Prince HM
Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
[No Abstract] [Full Text] [Related]
18. Genetic engineering of T cells in leukemia and lymphoma.
Kochenderfer JN
Clin Adv Hematol Oncol; 2014 Mar; 12(3):190-2. PubMed ID: 24927269
[No Abstract] [Full Text] [Related]
19. Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.
Faitschuk E; Hombach AA; Frenzel LP; Wendtner CM; Abken H
Blood; 2016 Sep; 128(13):1711-22. PubMed ID: 27535994
[TBL] [Abstract][Full Text] [Related]
20. CAR T Cells and Other Cellular Therapies for Multiple Myeloma: 2018 Update.
Cohen AD
Am Soc Clin Oncol Educ Book; 2018 May; 38():e6-e15. PubMed ID: 30231373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]